Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-26,967
Closed -$542K 2825
2023
Q4
$542K Sell
26,967
-197,708
-88% -$3.35M ﹤0.01% 1317
2023
Q3
$4.17M Buy
+224,675
New +$4.89M 0.04% 361
2022
Q3
Sell
-59,129
Closed -$1.42M 3270
2022
Q2
$1.42M Buy
59,129
+35,758
+153% +$959K 0.02% 734
2022
Q1
$720K Buy
+23,371
New +$840K 0.01% 1361
2021
Q4
Sell
-89,098
Closed -$3.87M 3762
2021
Q3
$3.87M Buy
89,098
+61,338
+221% +$2.67M 0.02% 409
2021
Q2
$1.28M Buy
+27,760
New +$1.28M 0.01% 868
2021
Q1
Sell
-8,950
Closed -$354K 2998
2020
Q4
$354K Sell
8,950
-28,696
-76% -$1.07M 0.01% 1198
2020
Q3
$1.47M Buy
+37,646
New +$1.44M 0.04% 348
2019
Q4
Sell
-12,638
Closed -$430K 1475
2019
Q3
$430K Buy
+12,638
New +$437K 0.02% 758

Other funds holding NEOG

HRT Financial's NEOG Position: Q1 2024 in Review

HRT Financial sold out of Neogen (NEOG) in Q1 2024, closing a stake of 26,967 shares — an estimated $542K sold.

HRT Financial first reported a position in NEOG in Q3 2019 and held it in 9 quarters. The position peaked at $4.17M in Q3 2023. 343 funds tracked by Wall St. Rank hold NEOG as of Q1 2024.

  • HRT Financial reported no remaining Neogen position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 26,967 Neogen shares in Q1 2024, an estimated $542K.
  • HRT Financial first reported a position in Neogen in Q3 2019 and held it in 9 quarters.
  • HRT Financial's Neogen position peaked at $4.17M in Q3 2023.
  • 343 funds tracked by Wall St. Rank held Neogen as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.